Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.

NOTE: This disposition is nonprecedential.

United States Court of Appeals
for the Federal Circuit
______________________

JANSSEN BIOTECH, INC.,
Plaintiff-Appellant

v.

CELLTRION HEALTHCARE CO., LTD.,
CELLTRION, INC., HOSPIRA, INC.,
Defendants-Cross-Appellants
______________________

2018-2321, 2018-2350
______________________

Appeals from the United States District Court for the
District of Massachusetts in No. 1:17-cv-11008-MLW,
Chief Judge Mark L. Wolf.
______________________

JUDGMENT
______________________

G
REGORY DISKANT, Patterson Belknap Webb & Tyler
LLP, New York, NY, argued for plaintiff-appellant. Also
represented by ANDREW D. COHEN, ARON RUSSELL FISCHER,
EUGENE M. GELERNTER.

JAMES F. HURST, Kirkland & Ellis LLP, Chicago, IL, ar-
gued for defendants-cross-appellants. Also represented by
B
RYAN SCOTT HALES; WILLIAM H. BURGESS, JOHN C.
O'QUINN, Washington, DC.
Case: 18-2321 Document: 81 Page: 1 Filed: 03/05/2020

______________________

THIS CAUSE having been heard and considered, it is

O
RDERED and ADJUDGED:

PER CURIAM (WALLACH, TARANTO, and STOLL, Circuit
Judges).
AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

March 5, 2020 /s/ Peter R. Marksteiner
Date Peter R. Marksteiner
Clerk of Court
Case: 18-2321 Document: 81 Page: 2 Filed: 03/05/2020